Indoco Remedies Limited has informed the Exchange about ECC on Audited Financial Results for the quarter and year ended 31-03-2026

Board & Shareholder Meetings View source PDF

INDOCO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+0.9%1-day move

₹208.10

prior close

₹208.10

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.1+0.9+0.9+0.9+0.9+0.5+1.9+4.3+11.0+9.5+1.2+0.9+11.8—

Up moveDown movePending

AI summary

Indoco Remedies Limited has announced an earnings conference call scheduled for Thursday, 7th May 2026 at 3:30 PM IST to discuss audited financial results for Q4 FY2025-26 and the full year ended 31st March 2026. The call will be hosted by Dolat Capital Market Pvt. Ltd. Key company representatives attending include Managing Director Ms. Aditi Panandikar, Jt. Managing Director Mr. Sundeep V. Bambolkar, and CFO Mr. Pramod Ghorpade. This intimation is pursuant to SEBI Listing Regulations. Dial-in details and registration links for international callers are provided in the filing.

Likely market impact

This is a routine announcement informing investors about an upcoming earnings call - no actual financial results or performance data are disclosed. The scheduled call indicates management engagement with shareholders and transparency in communication.